3Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey Ⅰ and Gyula Ostoros, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non- small cell lung cancer. Clin Cancer Res 2005, 11: 7344 -7353.
4Al-Rawi MA, Mansel RE and Jiang WG. Lymphangiogenesis and its role in cancer. Histol Histopathol 2005, 20: 283-298.
5Inoue A, Moriya H, Katada N, Tanabe S, Kobayashi N, Watanabe M and Okayasu I, et al. Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int 2008, 58:611- 619.
6Jackson DG. New molecular markers for the study of tumor lymphangiogenesis. Anticancer Res 2001, 21: 4279-4283.
7Da MX, Wu Z and Tian HW. Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 2008, 39:365- 372.
8Cao Y and Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother 2007, 61:534 -539.
9SU JL, Chen PS, Chien MH, Chen PB, Chen YH, Lai CC and Hung MC, et al. Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells. Cancer Cell 2008, 13: 557- 560.
10Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB and Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998, 12:1063- 1073.
3Da MX,Wu XT,Wang J,et al.Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer[J].Arch Med Res,2008,39 (1):92-99.
4Choi J,Oh Y,Park Y,et al.Correlation of vaacular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma[J].J Korean Med Sci,2008,23 (4) : 592-597.
